Purchase Order 75D30123P18058
Award Date 9/19/23
Potential Completion Date 9/18/24
Potential Value $250K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Coralville, IA 52241, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $850,007 fixed-price purchase order to Integrated DNA Technologies, Inc. for COVID-19 primers and probes. Under this contract, IDT will provide the CDC with reagents to support coronavirus detection and monitoring efforts through December 2020. No major subcontractors or set aside designations were indicated. The award draws on the CDC's expertise in disease control and public health preparedness...
- This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT) for the delivery of primers and probes. The contract, valued at $90,225.60, has a period of performance ending on March 13, 2020. IDT is a leading provider of specialized nucleic acid products and services to various federal agencies, including the CDC, supporting biomedical research, pandemic response, and public health initiatives. This award is...
- Integrated DNA Technologies, Inc., doing business as IDT, has been awarded a $13,669.50 purchase order contract by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania. Under the terms of the contract, IDT PRIMETIME PROBES, IDT will provide probe products to the CDC to support its disease prevention and health promotion efforts. Performance will take place in Coralville, Iowa over a period of approximately one month, concluding on October 2, 2023. The contract has a...
- This federal contract award was made by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. government. The $214,978.20 firm-fixed-price purchase order is for "RAPID OLIGO AND DNA" products and services, which likely includes custom DNA and RNA oligonucleotides, gene fragments, primers, probes, and other reagents to support the CDC's biomedical research,...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) for the delivery of primer kits and probe kits. The $154,671.98 contract has a completion date of October 2, 2020 and is associated with the Coronavirus COVID-19 national interest action. IDT, a manufacturer of nucleic acid products, has previously supplied the federal government with a range of goods and services including...
- Integrated DNA Technologies, Inc., doing business as IDT, has been awarded a $850,007 firm fixed price definitive contract by the Centers for Disease Control and Prevention (CDC) in Pittsburgh, Pennsylvania. Under the terms of the contract, IDT will provide laboratory supplies in support of CDC programs. As a leading provider of custom DNA oligonucleotides, IDT is well positioned to deliver the requested products. No subcontractors or set aside designations were specified. The one-year...
- This firm-fixed-price purchase order was awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT) for the provision of SPIKE PRIMER SETS AND AMPLICON PANEL, with a ceiling value of $187,940.00 and a period of performance ending on September 29, 2024. The award was made on a sole-source basis, as IDT is the only manufacturer of the proprietary "XGEN" technology validated by the CDC for whole genome sequencing of SARS-CoV-2 to support...
- The Centers for Disease Control and Prevention (CDC) awarded a $249,445 firm-fixed-price purchase order to Integrated DNA Technologies, Inc. (IDT) to provide oligonucleotides and gene production in support of the development of COVID-19 vaccine candidates. The award does not have a set-aside designation. IDT is a major provider of specialized nucleic acid products and services to federal agencies, including the NIH, CDC, DoD, and USDA, through prime contracts and subcontracts. The company...
- This is a firm-fixed-price purchase order awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT) for the provision of $91,594 worth of Zika primer and probes. The contract does not have a set-aside designation. Integrated DNA Technologies is a leading provider of specialized nucleic acid products and services to multiple federal agencies, including the CDC, NIH, DoD, and Department of Commerce. The company has a long history of supporting...
- This is a $2,425,869.00 firm-fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to Integrated DNA Technologies, Inc. (IDT), a leading provider of specialized nucleic acid products and services to the U.S. federal government. The contract, which has a period of performance through June 19, 2024, is for the procurement of oligonucleotides. IDT has supported a wide range of federal agencies, including the NIH, CDC, DoD, and Department of Commerce,...
The Centers for Disease Control and Prevention (CDC) awarded a $249,540 purchase order to Integrated DNA Technologies, Inc. (IDT) for pandemic rapid primers. IDT will provide primer products to the CDC under this firm fixed-price contract, which runs from September 2023 through September 2024. The place of performance for the contract is IDT's facility in Coralville, Iowa. As the nation's leading public health agency, the CDC works to protect public health and safety through the control and prevention of disease, injury, and disability. This award supports the CDC's efforts to develop testing capabilities for emerging public health threats. No set-aside designation or subcontractors were indicated.
Generated 12/23/23, 3:14 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $249.5k | 9/19/23 |